Literature DB >> 8254037

Naturally occurring anti-i/I cold agglutinins may be encoded by different VH3 genes as well as the VH4.21 gene segment.

L C Jefferies1, C M Carchidi, L E Silberstein.   

Abstract

In the current study, we wished to determine if the V regions encoding the naturally occurring anti-i/I Cold Agglutinins (anti-i/I CA) differ from pathogenic anti-i/I CA that are exclusively encoded by the VH4.21 gene. After EBV transformation of B lymphocytes, we generated one anti-I secreting clone from each of two individuals; clone 4G (individual CM, PBL) and clone Sp1 (individual SC, spleen). Clone 4G expresses a VH3 gene sequence that is 92% homologous to the germline gene WHG26. Clone Sp1 also expresses a VH3 gene that is 98% homologous to the fetally rearranged M85/20P1 gene. Another clone, Sp2 (anti-i specificity), from individual SC is 98% homologous to the germline gene VH4.21. For correlation, we studied anti-i/I CA fractions purified from 15 normal sera and found no or relatively small amounts of 9G4 (VH4.21 related idiotype) reactive IgM. Five cold agglutinin fractions contained large amounts of VH3-encoded IgM (compared to pooled normal IgM) by virtue of their binding to modified protein Staph A (SPA), and absorption of three CA fractions with modified SPA specifically removed anti-i/I binding specificity entirely. Collectively, the data indicate that naturally occurring anti-i/I CA may be encoded to a large extent by non-VH4.21-related genes, and that the VH4.21 gene is not uniquely required for anti-i/I specificity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8254037      PMCID: PMC288483          DOI: 10.1172/JCI116902

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  EXPERIMENTAL PRODUCTION OF COLD AGGLUTININS IN RABBITS.

Authors:  N COSTEA; V YAKULIS; P HELLER
Journal:  Blood       Date:  1965-09       Impact factor: 22.113

2.  Recurrent somatic mutations in mouse antibodies to p-azophenylarsonate increase affinity for hapten.

Authors:  J Sharon; M L Gefter; L J Wysocki; M N Margolies
Journal:  J Immunol       Date:  1989-01-15       Impact factor: 5.422

3.  Antibodies to shared idiotypes as agents for analysis and therapy for human B cell tumors.

Authors:  F K Stevenson; M Wrightham; M J Glennie; D B Jones; A R Cattan; T Feizi; T J Hamblin; G T Stevenson
Journal:  Blood       Date:  1986-08       Impact factor: 22.113

4.  Structure and function of anti-DNA autoantibodies derived from a single autoimmune mouse.

Authors:  M J Shlomchik; A H Aucoin; D S Pisetsky; M G Weigert
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

5.  Mixed gamma G-gamma M cold agglutinin.

Authors:  L S Goldberg; E V Barnett
Journal:  J Immunol       Date:  1967-10       Impact factor: 5.422

Review 6.  Biologic activity of cold-reacting autoantibodies (first of two parts).

Authors:  W Pruzanski; K H Shumak
Journal:  N Engl J Med       Date:  1977-09-08       Impact factor: 91.245

7.  Comparative biochemical and genetic characterization of clonally related human B-cell lines secreting pathogenic anti-Pr2 cold agglutinins.

Authors:  L E Silberstein; J Goldman; J A Kant; S L Spitalnik
Journal:  Arch Biochem Biophys       Date:  1988-07       Impact factor: 4.013

8.  Lupus serum and normal human serum contain anti-DNA antibodies with the same idiotypic marker.

Authors:  M P Madaio; A Schattner; M Shattner; R S Schwartz
Journal:  J Immunol       Date:  1986-10-15       Impact factor: 5.422

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Rheumatoid factor and immune networks.

Authors:  D A Carson; P P Chen; R I Fox; T J Kipps; F Jirik; R D Goldfien; G Silverman; V Radoux; S Fong
Journal:  Annu Rev Immunol       Date:  1987       Impact factor: 28.527

View more
  5 in total

1.  Immunoglobulin heavy and light chain gene features are correlated with primary cold agglutinin disease onset and activity.

Authors:  Agnieszka Małecka; Gunhild Trøen; Anne Tierens; Ingunn Østlie; Jędrzej Małecki; Ulla Randen; Sigbjørn Berentsen; Geir E Tjønnfjord; Jan M A Delabie
Journal:  Haematologica       Date:  2016-05-19       Impact factor: 9.941

2.  Human monoclonal antibodies encoded by the V4-34 gene segment show cold agglutinin activity and variable multireactivity which correlates with the predicted charge of the heavy-chain variable region.

Authors:  S J Thorpe; C E Turner; F K Stevenson; M B Spellerberg; R Thorpe; J B Natvig; K M Thompson
Journal:  Immunology       Date:  1998-01       Impact factor: 7.397

3.  Two acquired immunodeficiency syndrome-associated Burkitt's lymphomas produce specific anti-i IgM cold agglutinins using somatically mutated VH4-21 segments.

Authors:  P Riboldi; G Gaidano; E W Schettino; T G Steger; D M Knowles; R Dalla-Favera; P Casali
Journal:  Blood       Date:  1994-05-15       Impact factor: 22.113

4.  A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, V1-18.

Authors:  H J Willison; G M O'Hanlon; G Paterson; J Veitch; G Wilson; M Roberts; T Tang; A Vincent
Journal:  J Clin Invest       Date:  1996-03-01       Impact factor: 14.808

Review 5.  Primary chronic cold agglutinin disease: an update on pathogenesis, clinical features and therapy.

Authors:  Sigbjørn Berentsen; Klaus Beiske; Geir E Tjønnfjord
Journal:  Hematology       Date:  2007-10       Impact factor: 2.269

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.